Carregant...
Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant tumor with great variation in prognosis among individuals. Changes in metabolism influence disease progression and clinical outcomes. The objective of this study was to determine the overall survival (OS) risk of HCC patients from a metabolic...
Guardat en:
| Publicat a: | J Hepatocell Carcinoma |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8018394/ https://ncbi.nlm.nih.gov/pubmed/33824863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S300633 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|